Pneumatic Nebulizers Market Trends

Pneumatic Nebulizers Market Trends

The rising prevalence of asthma and COPD (chronic obstructive pulmonary disease) diseases will propel the industry growth. According to the World Health Organization, in 2019, around 262 million people suffered from asthma and it resulted in 4,61,000 deaths globally. The treatment of asthma and COPD is long-term may result in high healthcare expenditure. Furthermore, rising urbanization, declining quality of air, and high awareness regarding respiratory disease and treatment will further stimulate the demand for pneumatic nebulizers in the industry.
 

Risk of infection due to the nebulizers will slow down the market progression

The American Society of Microbiology (ASM) stated that regular use of pneumatic nebulizers at home setting will increase the risks of bacterial infection. The pneumatic nebulizers devices may host the growth of pathogens like Rhizobium, Stenotrophomonas, Staphylococcus, and Streptococcus. This has been negatively impacting the market and will continue to restrain the industry expansion in the coming years. Additionally, lower insurance coverage scenarios in developing economies will further restrict the industry value during the forecast period.